Concepedia

Publication | Open Access

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

746

Citations

23

References

2021

Year

Abstract

ClinicalTrials.gov Identifier: NCT03691090.

References

YearCitations

Page 1